Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
02:30am, Tuesday, 29'th Oct 2024
QIAstat-Dx Respiratory Panel Mini targets the five most actionable respiratory pathogens in outpatient settings to help clinicians make precise treatment decisions // With the new test and the 21-targ
QIAGEN's TB Testing Business Gets New Exposure at Global Summit
10:31am, Friday, 11'th Oct 2024
QGEN distributes over 125 million QuantiFERON-TB tests across more than 130 countries worldwide, significantly contributing to national TB control strategies.
QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
04:05pm, Thursday, 10'th Oct 2024
Portfolio expansion reinforces QIAGEN's leadership in automated solutions for non-invasive liquid biopsy applications combined with complete workflows // New ccfDNA Kit upgrade with urine protocol for
QIAGEN N.V. to release results for Q3 2024 and hold webcast
07:41am, Thursday, 10'th Oct 2024
Venlo, The Netherlands, Oct. 10, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the third quarter 2024.
Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
04:05pm, Monday, 07'th Oct 2024
QIAGEN's leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission // Over 35 top
Reasons to Retain QIAGEN Stock in Your Portfolio for Now
03:15pm, Monday, 07'th Oct 2024
Investors feel optimistic about QGEN's strong growth prospects in the NGS platforms. Yet, an unfavorable currency impact on the company's operations is cornering.
QIAGEN Launches QIAcuityDx Digital PCR System: Stock to Gain?
11:16am, Tuesday, 01'st Oct 2024
QGEN expands its digital PCR portfolio with the newly launched QIAcuityDx Digital PCR System. The system will be used for clinical testing in oncology across North America and Europe.
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
04:05pm, Monday, 30'th Sep 2024
Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise mo
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels
10:05am, Friday, 27'th Sep 2024
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays.
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
04:05pm, Thursday, 26'th Sep 2024
Product line earns CE-marking under new EU IVDR framework – including QIAstat-Dx Analyzer, QIAstat-Dx Rise and panels for detection of gastrointestinal and respiratory infections // Certification co
QIAGEN Stock Likely to Gain From PreAnalytiX's Newly Launched PAXgene
10:06am, Thursday, 26'th Sep 2024
PreAnalytiX, a joint venture of QGEN and BD, introduces the PAXgene Urine Liquid Biopsy Set. QGEN will commercialize the latest set.
PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples
04:05pm, Wednesday, 25'th Sep 2024
PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA stabilization from urine // QIAGEN to commercial
QGEN Stock Might Rise on Partnership With Bode for GEDmatch PRO
09:45am, Tuesday, 24'th Sep 2024
QIAGEN announces exclusive global commercial partnership with Bode Technology. Per the agreement, Bode will manage all commercial transactions for QIAGEN's GEDmatch PRO globally.
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
04:05pm, Monday, 23'rd Sep 2024
QIAGEN chooses Bode Technology as its exclusive global commercial partner to accelerate use of GEDmatch PRO genealogy database in law enforcement and identification of human remains // Collaboration e
QGEN Stock Likely to Gain From Newly Launched Assays for QIAcuity
11:16am, Thursday, 19'th Sep 2024
QIAGEN launches 100 new assays for QIAcuity. The newly launched assays are now available through the company?
